Ivermectin

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

Rosacea and Ivermectin

Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

Moxidectin for LF, Cote d'Ivoire (DOLF)

Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases

ACTIV-6: COVID-19 Study of Repurposed Medications

Repeat Ivermectin Mass Drug Administrations for MALaria Control II

Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis

Effect of Ivermectin Metabolites on Mosquito Survival

Insecticide Resistance Management in Burkina Faso and Côte D'Ivoire

Trial of Combination Therapy to Treat COVID-19 Infection

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

Emodepside Phase II Trial for Treatment of Onchocerciasis

Oral Ivermectin for Chikungunya Viral Infection

Treatment of Strongyloides Infection